Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Verträglichkeit (9 Abbildungen)
Übersicht


Zum ersten Bild Abb. 2: Telmisartan - Placebo - Verträglichkeit Abb. 3: Telmisartan - Verträglichkeit Abb. 4: Telmisartan - HCTZ - Verträglichkeit Abb. 5: Verträglichkeitsprofil Abb. 6: Verträglichkeitsprofil Aktuelles Bild - Abb. 7: Verträglichkeitsprofil Abb. 8: HCTZ - Hypokaliämische Einflüsse Abb. 9: Verträglichkeit
Abbildung 7: Verträglichkeitsprofil
This study, A comparison of Telmisartan plus HCTZ with amlodipine plus HCTZ in Older patients with predominantly Systolic hypertension (ATHOS), compared telmisartan 40–80 mg + HCTZ 12.5 mg and amlodipine 5–10 mg + HCTZ 12.5 mg.1 There were more adverse events in the amlodipine group than in the telmisartan group. The most frequently reported adverse event was peripheral oedema, reported in 6 (1.2%) patients taking telmisartan + HCTZ, compared with 122 (24.3%) patients taking amlodipine + HCTZ. This led to a higher overall discontinuation rate from adverse events in the amlodipine group compared with the telmisartan group. Data on file. Boehringer Ingelheim, GmbH.
 
Verträglichkeitsprofil
Vorheriges Bild Nächstes Bild   


Abbildung 7: Verträglichkeitsprofil
This study, A comparison of Telmisartan plus HCTZ with amlodipine plus HCTZ in Older patients with predominantly Systolic hypertension (ATHOS), compared telmisartan 40–80 mg + HCTZ 12.5 mg and amlodipine 5–10 mg + HCTZ 12.5 mg.1 There were more adverse events in the amlodipine group than in the telmisartan group. The most frequently reported adverse event was peripheral oedema, reported in 6 (1.2%) patients taking telmisartan + HCTZ, compared with 122 (24.3%) patients taking amlodipine + HCTZ. This led to a higher overall discontinuation rate from adverse events in the amlodipine group compared with the telmisartan group. Data on file. Boehringer Ingelheim, GmbH.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung